Your browser doesn't support javascript.
loading
International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia.
Oerlemans, Simone; Efficace, Fabio; Kieffer, Jacobien M; Kyriakou, Charalampia; Xochelli, Aliki; Levedahl, Kerstin; Petranovic, Duska; Borges, Fabio Cardoso; Bredart, Anne; Shamieh, Omar; Gziskevicius, Laimonas; Lehmann, Jens; Scholz, Christian W; Caocci, Giovanni; Molica, Stefano; Stamatopoulos, Kostas; Panteliadou, Alkistis-Kyra; Papaioannou, Maria; Alrjoob, Waleed; Baliakas, Panagiotis; Rosenquist, Richard; Malak, Sandra; Miranda, Ana; Cocks, Kim; van de Poll-Franse, Lonneke.
Afiliação
  • Oerlemans S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Efficace F; Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA) Data Centre, Rome, Italy.
  • Kieffer JM; Department of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kyriakou C; University College London Hospital, London, UK.
  • Xochelli A; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Levedahl K; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Petranovic D; Clinical Hospital Center Rijeka, University of Rijeka, Rijeka, Croatia.
  • Borges FC; Department of Epidemiology and National Cancer Registry (RON), Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E, Lisbon, Portugal.
  • Bredart A; Institut Curie - Psycho-Oncology Unit, Paris University, Paris, France.
  • Shamieh O; Psychopathology and Health Process Laboratory (LPPS) (UR 4057), PSL University, Paris, France.
  • Gziskevicius L; Department of Palliative Medicine, King Hussein Cancer Center, Amman, Jordan.
  • Lehmann J; University Hospital, Vilnius, Lithuania.
  • Scholz CW; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
  • Caocci G; Hematology and Oncology, Vivantes Klinikum Am Urban, Berlin, Germany.
  • Molica S; Hematology, Businco Hospital, University of Cagliari, Cagliari, Italy.
  • Stamatopoulos K; Azienda Ospedalier Ciaccio, Catanzaro, Italy.
  • Panteliadou AK; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Papaioannou M; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Alrjoob W; Hematology Unit, 1st Dept of Internal Medicine, AUTH, AHEPA Hospital, Thessaloniki, Greece.
  • Baliakas P; Department of Palliative Medicine, King Hussein Cancer Center, Amman, Jordan.
  • Rosenquist R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Malak S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Miranda A; Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
  • Cocks K; Hôpital René Huguenin-Institut Curie - Hématologie, Saint-Cloud, France.
  • van de Poll-Franse L; Department of Epidemiology and National Cancer Registry (RON), Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E, Lisbon, Portugal.
Br J Haematol ; 197(4): 431-441, 2022 05.
Article em En | MEDLINE | ID: mdl-35255152

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Leucemia Linfocítica Crônica de Células B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Leucemia Linfocítica Crônica de Células B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article